TherapeuticsMD, Inc. 8-K

What Happened
TherapeuticsMD, Inc. announced that on January 15, 2026 its Audit Committee approved the appointment of Carr, Riggs & Ingram, L.L.C. (CRI) as the company’s independent registered public accounting firm, effective immediately. Berkowitz Pollack Brant Advisors + CPAs (BPB), the prior auditor, ceased serving as a result of a transaction in which CRI acquired certain assets related to BPB’s capital markets practice. BPB’s audit reports for the fiscal years ended December 31, 2024 and December 31, 2023 did not include an adverse opinion or disclaimer, but did include an explanatory paragraph about uncertainty regarding the company’s ability to continue as a going concern.

Key Details

• Appointment effective: January 15, 2026; new auditor: Carr, Riggs & Ingram, L.L.C. (CRI).
• Prior auditor ceased due to a transaction in which CRI acquired certain capital markets assets from BPB.
• BPB’s audit reports for FY 2024 and FY 2023 included a going-concern explanatory paragraph but contained no adverse or qualified opinions.
• The company reports no “disagreements” or “reportable events” with BPB for the years ended Dec 31, 2025 and Dec 31, 2024 through the dismissal; a BPB letter to the SEC dated Jan 20, 2026 is attached as Exhibit 16.1.
• Neither the company nor its representatives consulted CRI on accounting or auditing matters for the years ended Dec 31, 2025 and Dec 31, 2024 prior to CRI’s appointment.

Why It Matters
A change in independent auditor is a material corporate governance event that investors watch for continuity and quality of financial reporting. The prior auditor’s going-concern explanatory paragraph highlights an existing risk previously disclosed about the company’s ability to continue operations. At the same time, the filing states there were no disagreements or reportable events with the prior auditor, which reduces the likelihood the change was due to a dispute over accounting or audit matters. Investors should note the auditor change and continue to monitor upcoming financial filings for any changes in audit opinions or new disclosures about the company’s financial condition.